XML 66 R53.htm IDEA: XBRL DOCUMENT v3.6.0.2
Subsidiary Guarantors for 2036 Notes (Tables) - Supplemental Subsidiary Guarantors
12 Months Ended
Oct. 28, 2016
Condensed Financial Statements, Captions [Line Items]  
Supplemental Subsidiary Guarantor Condensed Consolidated Statement of Income
Condensed Consolidated Statement of Operations
Fiscal Year Ended October 28, 2016
In thousands
Parent
Company
 
Subsidiary
Guarantors
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
1,165,721

 
$
1,887,270

 
$
(681,591
)
 
$
2,371,400

Cost of sales

 
958,222

 
1,435,313

 
(537,961
)
 
1,855,574

Product development, selling and administrative expenses
58,923

 
176,085

 
242,399

 
(723
)
 
476,684

Restructuring and other impairment charges
395

 
39,957

 
49,544

 

 
89,896

Other (income) expense

 
5,065

 
(14,407
)
 

 
(9,342
)
Operating (loss) income
(59,318
)
 
(13,608
)
 
174,421

 
(142,907
)
 
(41,412
)
Intercompany items
55,152

 
(336,409
)
 
105,867

 
175,390

 

Interest (expense) income, net
(50,031
)
 
1,920

 
2,352

 

 
(45,759
)
(Loss) income from continuing operations before income taxes and equity in income of subsidiaries
(54,197
)
 
(348,097
)
 
282,640

 
32,483

 
(87,171
)
(Benefit) provision for income taxes
(24,165
)
 
(16,310
)
 
17,149

 

 
(23,326
)
Equity in (loss) income of subsidiaries
(28,347
)
 
254,320

 

 
(225,973
)
 

(Loss) income from continuing operations
$
(58,379
)
 
$
(77,467
)
 
$
265,491

 
$
(193,490
)
 
$
(63,845
)
 
 
 
 
 
 
 
 
 
 
Comprehensive (loss) income
$
(57,058
)
 
$
(76,876
)
 
$
286,431

 
$
(209,555
)
 
$
(57,058
)

Condensed Consolidated Statement of Operations
Fiscal Year Ended October 30, 2015
In thousands
Parent
Company
 
Subsidiary
Guarantors
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
1,801,405

 
$
2,330,469

 
$
(959,727
)
 
$
3,172,147

Cost of sales

 
1,339,541

 
1,732,574

 
(738,890
)
 
2,333,225

Product development, selling and administrative expenses
47,604

 
169,935

 
365,653

 
26

 
583,218

Goodwill impairment charges

 
133,413

 
1,065,843

 

 
1,199,256

Restructuring and other impairment charges

 
50,596

 
121,844

 

 
172,440

Other (income) expense
68

 
17,534

 
(24,205
)
 

 
(6,603
)
Operating (loss) income
(47,672
)
 
90,386

 
(931,240
)
 
(220,863
)
 
(1,109,389
)
Intercompany items
66,408

 
(107,484
)
 
48,415

 
(7,339
)
 

Loss on early debt retirement
(14,311
)
 

 

 

 
(14,311
)
Interest (expense) income, net
(63,138
)
 
6,769

 
2,940

 

 
(53,429
)
Loss from continuing operations before income taxes and equity in income of subsidiaries
(58,713
)
 
(10,329
)
 
(879,885
)
 
(228,202
)
 
(1,177,129
)
Provision (benefit) for income taxes
(3,807
)
 
17,886

 
(13,204
)
 

 
875

Equity in loss of subsidiaries
(1,123,098
)
 
(39,946
)
 

 
1,163,044

 

Loss from continuing operations
$
(1,178,004
)
 
$
(68,161
)
 
$
(866,681
)
 
$
934,842

 
$
(1,178,004
)
 
 
 
 
 
 
 
 
 
 
Comprehensive loss
$
(1,318,796
)
 
$
(69,263
)
 
$
(1,019,963
)
 
$
1,089,226

 
$
(1,318,796
)


Condensed Consolidated Statement of Operations
Fiscal Year Ended October 31, 2014
In thousands
Parent
Company
 
Subsidiary
Guarantors
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
2,127,333

 
$
2,568,580

 
$
(917,603
)
 
$
3,778,310

Cost of sales
700

 
1,542,011

 
1,876,783

 
(765,261
)
 
2,654,233

Product development, selling and administrative expenses
60,942

 
232,474

 
293,873

 

 
587,289

Restructuring and other impairment charges

 
3,759

 
17,838

 

 
21,597

Other (income) expense
(473
)
 
12,667

 
(24,529
)
 

 
(12,335
)
Operating income (loss)
(61,169
)
 
336,422

 
404,615

 
(152,342
)
 
527,526

Intercompany items
64,185

 
(77,048
)
 
(29,099
)
 
41,962

 

Interest (expense) income, net
(63,639
)
 
6,750

 
1,541

 

 
(55,348
)
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries
(60,623
)
 
266,124

 
377,057

 
(110,380
)
 
472,178

Provision (benefit) for income taxes
(46,296
)
 
155,459

 
24,897

 

 
134,060

Equity in income of subsidiaries
352,445

 
165,942

 

 
(518,387
)
 

Income from continuing operations
$
338,118

 
$
276,607

 
$
352,160

 
$
(628,767
)
 
$
338,118

 
 
 
 
 
 
 
 
 
 
Comprehensive income
$
301,810

 
$
281,569

 
$
311,369

 
$
(592,938
)
 
$
301,810

Condensed Consolidated Statement of Operations
Fiscal Year Ended October 28, 2016
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
1,173,777

 
$
1,879,214

 
$
(681,591
)
 
$
2,371,400

Cost of sales

 
964,866

 
1,428,669

 
(537,961
)
 
1,855,574

Product development, selling and administrative expenses
58,923

 
176,739

 
241,745

 
(723
)
 
476,684

Restructuring and other impairment charges
395

 
39,957

 
49,544

 

 
89,896

Other (income) expense

 
5,045

 
(14,387
)
 

 
(9,342
)
Operating (loss) income
(59,318
)
 
(12,830
)
 
173,643

 
(142,907
)
 
(41,412
)
Intercompany items
55,152

 
(336,409
)
 
105,867

 
175,390

 

Interest (expense) income, net
(50,031
)
 
1,949

 
2,323

 

 
(45,759
)
(Loss) income from continuing operations before income taxes and equity in income of subsidiaries
(54,197
)
 
(347,290
)
 
281,833

 
32,483

 
(87,171
)
(Benefit) provision for income taxes
(24,165
)
 
(16,533
)
 
17,372

 

 
(23,326
)
Equity in (loss) income of subsidiaries
(28,347
)
 
253,290

 

 
(224,943
)
 

(Loss) income from continuing operations
$
(58,379
)
 
$
(77,467
)
 
$
264,461

 
$
(192,460
)
 
$
(63,845
)
 
 
 
 
 
 
 
 
 
 
Comprehensive (loss) income
$
(57,058
)
 
$
(76,876
)
 
$
285,401

 
$
(208,525
)
 
$
(57,058
)

Condensed Consolidated Statement of Operations
Year Ended October 30, 2015
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
1,808,535

 
$
2,323,339

 
$
(959,727
)
 
$
3,172,147

Cost of sales

 
1,346,760

 
1,725,355

 
(738,890
)
 
2,333,225

Product development, selling and administrative expenses
47,604

 
169,935

 
365,653

 
26

 
583,218

Goodwill impairment charges

 
133,413

 
1,065,843

 

 
1,199,256

Restructuring and other impairment charges

 
50,596

 
121,844

 

 
172,440

Other (income) expense
68

 
17,519

 
(24,190
)
 

 
(6,603
)
Operating (loss) income
(47,672
)
 
90,312

 
(931,166
)
 
(220,863
)
 
(1,109,389
)
Intercompany items
66,408

 
(107,484
)
 
48,415

 
(7,339
)
 

Loss on early debt retirement
(14,311
)
 

 

 

 
(14,311
)
Interest (expense) income, net
(63,138
)
 
6,497

 
3,212

 

 
(53,429
)
Loss from continuing operations before income taxes and equity in income of subsidiaries
(58,713
)
 
(10,675
)
 
(879,539
)
 
(228,202
)
 
(1,177,129
)
Provision (benefit) for income taxes
(3,807
)
 
17,871

 
(13,189
)
 

 
875

Equity in loss of subsidiaries
(1,123,098
)
 
(39,615
)
 

 
1,162,713

 

Loss from continuing operations
$
(1,178,004
)
 
$
(68,161
)
 
$
(866,350
)
 
$
934,511

 
$
(1,178,004
)
 
 
 
 
 
 
 
 
 
 
Comprehensive loss
$
(1,318,796
)
 
$
(69,263
)
 
$
(1,019,632
)
 
$
1,088,895

 
$
(1,318,796
)

Condensed Consolidated Statement of Operations
Year Ended October 31, 2014
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
Net sales
$

 
$
2,139,999

 
$
2,555,914

 
$
(917,603
)
 
$
3,778,310

Cost of sales
700

 
1,552,326

 
1,866,468

 
(765,261
)
 
2,654,233

Product development, selling and administrative expenses
60,942

 
233,340

 
293,007

 

 
587,289

Restructuring and other impairment charges

 
3,759

 
17,838

 

 
21,597

Other (income) expense
(473
)
 
12,270

 
(24,132
)
 

 
(12,335
)
Operating income (loss)
(61,169
)
 
338,304

 
402,733

 
(152,342
)
 
527,526

Intercompany items
64,185

 
(77,048
)
 
(29,099
)
 
41,962

 

Interest (expense) income, net
(63,639
)
 
6,641

 
1,650

 

 
(55,348
)
Income (loss) from continuing operations before income taxes and equity in income of subsidiaries
(60,623
)
 
267,897

 
375,284

 
(110,380
)
 
472,178

Provision (benefit) for income taxes
(46,296
)
 
154,570

 
25,786

 

 
134,060

Equity in income of subsidiaries
352,445

 
165,942

 

 
(518,387
)
 

Income from continuing operations
$
338,118


$
279,269

 
$
349,498

 
$
(628,767
)
 
$
338,118

 
 
 
 
 
 
 
 
 
 
Comprehensive income
$
301,810

 
$
281,569

 
$
311,369

 
$
(592,938
)
 
$
301,810

Supplemental Subsidiary Guarantor Condensed Consolidated Balance Sheet
Condensed Consolidating Balance Sheet
As of October 28, 2016
In thousands
Parent
Company
 
Subsidiary
Guarantors
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 


Cash and cash equivalents
$
131,344

 
$
21,476

 
$
123,889

 
$

 
$
276,709

Accounts receivable, net
3

 
186,332

 
515,418

 
(17,795
)
 
683,958

Inventories

 
377,875

 
502,162

 
(65,216
)
 
814,821

Other current assets
6,418

 
5,996

 
101,463

 

 
113,877

Assets held for sale

 
3,703

 

 

 
3,703

Total current assets
137,765

 
595,382

 
1,242,932

 
(83,011
)
 
1,893,068

Property, plant and equipment, net
18,521

 
214,488

 
427,645

 
(4,409
)
 
656,245

Other assets:
 
 
 
 
 
 
 
 


Other intangible assets, net

 
187,018

 
36,393

 

 
223,411

Goodwill

 
341,984

 
8,859

 

 
350,843

Deferred income taxes
154,267

 

 
17,508

 

 
171,775

Other non-current assets
2,353,718

 
1,864,321

 
3,049,371

 
(7,136,321
)
 
131,089

Total other assets
2,507,985

 
2,393,323

 
3,112,131

 
(7,136,321
)
 
877,118

Total assets
$
2,664,271

 
$
3,203,193

 
$
4,782,708

 
$
(7,223,741
)
 
$
3,426,431

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings, including current portion of long-term obligations
$
37,500

 
$

 
$
4,554

 
$

 
$
42,054

Trade accounts payable
4,013

 
80,848

 
151,926

 

 
236,787

Employee compensation and benefits
8,346

 
28,363

 
54,515

 

 
91,224

Advance payments and progress billings

 
69,174

 
104,427

 
(480
)
 
173,121

Accrued warranties

 
16,909

 
23,878

 

 
40,787

Other accrued liabilities
87,958

 
38,376

 
67,801

 
(5,544
)
 
188,591

Total current liabilities
137,817

 
233,670

 
407,101

 
(6,024
)
 
772,564

Long-term obligations
964,939

 

 
40

 

 
964,979

Other liabilities:
 
 
 
 
 
 
 
 


Liabilities for postretirement benefits
14,260

 

 

 

 
14,260

Accrued pension costs
175,120

 

 

 

 
175,120

Other non-current liabilities
(9,571
)
 
9,832

 
117,541

 

 
117,802

Total other liabilities
179,809

 
9,832

 
117,541

 

 
307,182

Shareholders’ equity
1,381,706

 
2,959,691

 
4,258,026

 
(7,217,717
)
 
1,381,706

Total liabilities and shareholders’ equity
$
2,664,271

 
$
3,203,193

 
$
4,782,708

 
$
(7,223,741
)
 
$
3,426,431


Condensed Consolidating Balance Sheet
As of October 30, 2015
In thousands
Parent
Company
 
Subsidiary
Guarantors
 
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 


Cash and cash equivalents
$
581

 
$
2,008

 
$
100,296

 
$

 
$
102,885

Accounts receivable, net

 
214,381

 
597,826

 
(134
)
 
812,073

Inventories

 
508,774

 
607,461

 
(108,310
)
 
1,007,925

Other current assets
58,441

 
15,610

 
71,508

 

 
145,559

Total current assets
59,022

 
740,773

 
1,377,091

 
(108,444
)
 
2,068,442

Property, plant and equipment, net
21,318

 
297,476

 
478,253

 
(5,015
)
 
792,032

Other assets:
 
 
 
 
 
 
 
 


Other intangible assets, net

 
207,891

 
47,819

 

 
255,710

Goodwill

 
346,348

 
8,273

 

 
354,621

Deferred income taxes
49,660

 

 
69,253

 

 
118,913

Other non-current assets
2,740,518

 
2,078,294

 
2,517,110

 
(7,213,194
)
 
122,728

Total other assets
2,790,178

 
2,632,533

 
2,642,455

 
(7,213,194
)
 
851,972

Total assets
$
2,870,518

 
$
3,670,782

 
$
4,497,799

 
$
(7,326,653
)
 
$
3,712,446

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings, including current portion of long-term obligations
$
18,750

 
$

 
$
7,571

 
$

 
$
26,321

Trade accounts payable
3,342

 
96,891

 
175,556

 

 
275,789

Employee compensation and benefits
5,843

 
36,527

 
47,965

 

 
90,335

Advance payments and progress billings

 
100,312

 
149,795

 
(20,637
)
 
229,470

Accrued warranties

 
19,027

 
33,119

 

 
52,146

Other accrued liabilities
76,650

 
60,228

 
100,660

 
(12,261
)
 
225,277

Current liabilities of discontinued operations

 
11,582

 

 

 
11,582

Total current liabilities
104,585

 
324,567

 
514,666

 
(32,898
)
 
910,920

Long-term obligations
1,060,598

 

 
45

 

 
1,060,643

Other liabilities:
 
 
 
 
 
 
 
 


Liabilities for postretirement benefits
18,662

 
878

 

 

 
19,540

Accrued pension costs
159,594

 
8,406

 
7,699

 

 
175,699

Other non-current liabilities
81,595

 
8,325

 
35,715

 

 
125,635

Total other liabilities
259,851

 
17,609

 
43,414

 

 
320,874

Shareholders’ equity
1,445,484

 
3,328,606

 
3,939,674

 
(7,293,755
)
 
1,420,009

Total liabilities and shareholders’ equity
$
2,870,518

 
$
3,670,782

 
$
4,497,799

 
$
(7,326,653
)
 
$
3,712,446

Condensed Consolidating Balance Sheet
As of October 28, 2016
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
131,344

 
$
21,476

 
$
123,889

 
$

 
$
276,709

Accounts receivable, net
3

 
186,332

 
515,418

 
(17,795
)
 
683,958

Inventories

 
377,875

 
502,162

 
(65,216
)
 
814,821

Other current assets
6,418

 
5,996

 
101,463

 

 
113,877

Assets held for sale

 
3,703

 

 

 
3,703

Total current assets
137,765

 
595,382

 
1,242,932

 
(83,011
)
 
1,893,068

Property, plant and equipment, net
18,521

 
214,488

 
427,645

 
(4,409
)
 
656,245

Other assets:
 
 
 
 
 
 
 
 


Other intangible assets, net

 
187,018

 
36,393

 

 
223,411

Goodwill

 
341,984

 
8,859

 

 
350,843

Deferred income taxes
154,267

 

 
17,508

 

 
171,775

Other non-current assets
2,353,718

 
1,864,321

 
3,049,371

 
(7,136,321
)
 
131,089

Total other assets
2,507,985

 
2,393,323

 
3,112,131

 
(7,136,321
)
 
877,118

Total assets
$
2,664,271

 
$
3,203,193

 
$
4,782,708

 
$
(7,223,741
)
 
$
3,426,431

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings, including current portion of long-term obligations
$
37,500

 
$

 
$
4,554

 
$

 
$
42,054

Trade accounts payable
4,013

 
80,848

 
151,926

 

 
236,787

Employee compensation and benefits
8,346

 
28,363

 
54,515

 

 
91,224

Advance payments and progress billings

 
69,174

 
104,427

 
(480
)
 
173,121

Accrued warranties

 
16,909

 
23,878

 

 
40,787

Other accrued liabilities
87,958

 
38,376

 
67,801

 
(5,544
)
 
188,591

Total current liabilities
137,817

 
233,670

 
407,101

 
(6,024
)
 
772,564

Long-term obligations
964,939

 

 
40

 

 
964,979

Other liabilities:
 
 
 
 
 
 
 
 


Liabilities for postretirement benefits
14,260

 

 

 

 
14,260

Accrued pension costs
175,120

 

 

 

 
175,120

Other non-current liabilities
(9,571
)
 
9,832

 
117,541

 

 
117,802

Total other liabilities
179,809

 
9,832

 
117,541

 

 
307,182

Shareholders’ equity
1,381,706

 
2,959,691

 
4,258,026

 
(7,217,717
)
 
1,381,706

Total liabilities and shareholders’ equity
$
2,664,271

 
$
3,203,193

 
$
4,782,708

 
$
(7,223,741
)
 
$
3,426,431


Condensed Consolidating Balance Sheet
As of October 30, 2015
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Eliminations
 
Consolidated
ASSETS
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 


Cash and cash equivalents
$
581

 
$
2,008

 
$
100,296

 
$

 
$
102,885

Accounts receivable, net

 
214,381

 
597,826

 
(134
)
 
812,073

Inventories

 
508,774

 
607,461

 
(108,310
)
 
1,007,925

Other current assets
58,441

 
15,610

 
71,508

 

 
145,559

Total current assets
59,022

 
740,773

 
1,377,091

 
(108,444
)
 
2,068,442

Property, plant and equipment, net
21,318

 
297,476

 
478,253

 
(5,015
)
 
792,032

Other assets:
 
 
 
 
 
 
 
 


Other intangible assets, net

 
207,891

 
47,819

 

 
255,710

Goodwill

 
346,348

 
8,273

 

 
354,621

Deferred income taxes
49,660

 

 
69,253

 

 
118,913

Other non-current assets
2,740,518

 
2,078,294

 
2,517,110

 
(7,213,194
)
 
122,728

Total other assets
2,790,178

 
2,632,533

 
2,642,455

 
(7,213,194
)
 
851,972

Total assets
$
2,870,518

 
$
3,670,782

 
$
4,497,799

 
$
(7,326,653
)
 
$
3,712,446

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
Short-term borrowings, including current portion of long-term obligations
$
18,750

 
$

 
$
7,571

 
$

 
$
26,321

Trade accounts payable
3,342

 
96,891

 
175,556

 

 
275,789

Employee compensation and benefits
5,843

 
36,527

 
47,965

 

 
90,335

Advance payments and progress billings

 
100,312

 
149,795

 
(20,637
)
 
229,470

Accrued warranties

 
19,027

 
33,119

 

 
52,146

Other accrued liabilities
76,650

 
60,228

 
100,660

 
(12,261
)
 
225,277

Current liabilities of discontinued operations

 
11,582

 

 

 
11,582

Total current liabilities
104,585

 
324,567

 
514,666

 
(32,898
)
 
910,920

Long-term obligations
1,060,598

 

 
45

 

 
1,060,643

Other liabilities:
 
 
 
 
 
 
 
 


Liabilities for postretirement benefits
18,662

 
878

 

 

 
19,540

Accrued pension costs
159,594

 
8,406

 
7,699

 

 
175,699

Other non-current liabilities
81,595

 
8,325

 
35,715

 

 
125,635

Total other liabilities
259,851

 
17,609

 
43,414

 

 
320,874

Shareholders’ equity
1,445,484

 
3,328,606

 
3,939,674

 
(7,293,755
)
 
1,420,009

Total liabilities and shareholders’ equity
$
2,870,518

 
$
3,670,782

 
$
4,497,799

 
$
(7,326,653
)
 
$
3,712,446

Supplemental Subsidiary Guarantor Condensed Consolidated Statement of Cash Flows
Condensed Consolidating Statement of Cash Flows
Year Ended October 28, 2016
In thousands
Parent
Company
 
Subsidiary
Guarantors
 
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 


Net cash provided (used) by operating activities
$
213,831

 
$
(17,962
)
 
$
57,772

 
$
253,641

Investing Activities:
 
 
 
 
 
 


Property, plant and equipment acquired
(618
)
 
(8,883
)
 
(33,189
)
 
(42,690
)
Proceeds from sale of business

 
28,250

 

 
28,250

Proceeds from sale of property, plant and equipment

 
18,063

 
6,775

 
24,838

Other investing activities, net
(744
)
 

 

 
(744
)
Net cash provided (used) by investing activities
(1,362
)
 
37,430

 
(26,414
)
 
9,654

Financing Activities:
 
 
 
 
 
 


Common stock issued
639

 

 

 
639

Dividends paid
(3,984
)
 

 

 
(3,984
)
Repayments of Term Loan
(18,750
)
 

 

 
(18,750
)
Payments on Credit Agreement
(58,600
)
 

 

 
(58,600
)
Financing fees
(1,011
)
 

 

 
(1,011
)
Other financing activities, net

 

 
(2,984
)
 
(2,984
)
Net cash used by financing activities
(81,706
)



(2,984
)

(84,690
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 
(3,271
)
 
(3,271
)
Increase in cash, cash equivalents and restricted cash
130,763

 
19,468

 
25,103

 
175,334

Cash, cash equivalents and restricted cash at beginning of period
581

 
2,008

 
100,296

 
102,885

Cash, cash equivalents and restricted cash at end of period
$
131,344

 
$
21,476

 
$
125,399

 
$
278,219


Condensed Consolidating Statement of Cash Flows
Year Ended October 30, 2015
In thousands
Parent
Company
 
Subsidiary
Guarantors
 
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 


Net cash provided by operating activities
261,293

 
16,105

 
77,935

 
355,333

Investing Activities:
 
 
 
 
 
 

Acquisition of businesses, net of cash acquired

 

 
(114,353
)
 
(114,353
)
Property, plant and equipment acquired
(945
)
 
(19,108
)
 
(51,283
)
 
(71,336
)
Proceeds from sale of property, plant and equipment
942

 
216

 
3,142

 
4,300

Other investing activities, net
(1,148
)
 

 
1,065

 
(83
)
Net cash used by investing activities
(1,151
)
 
(18,892
)
 
(161,429
)
 
(181,472
)
Financing Activities:

 


 


 


Common stock issued
4,654

 

 

 
4,654

Dividends paid
(77,950
)
 

 

 
(77,950
)
Redemption of 6% note due 2016
(250,000
)
 

 

 
(250,000
)
Borrowings on Credit Agreement
58,600

 

 

 
58,600

Treasury stock purchased
(50,000
)
 

 

 
(50,000
)
Other financing activities, net
261

 
(11,634
)
 
1,113

 
(10,260
)
Net cash (used) provided by financing activities
(314,435
)
 
(11,634
)
 
1,113

 
(324,956
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 
(16,211
)
 
(16,211
)
Decrease in cash, cash equivalents and restricted cash
(54,293
)
 
(14,421
)
 
(98,592
)
 
(167,306
)
Cash, cash equivalents and restricted cash at beginning of period
54,874

 
16,429

 
198,888

 
270,191

Cash, cash equivalents and restricted cash at end of period
$
581

 
$
2,008

 
$
100,296

 
$
102,885



Condensed Consolidating Statement of Cash Flows
Year Ended October 31, 2014
In thousands
Parent
Company
 
Subsidiary
Guarantors
 
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 


Net cash provided by operating activities of continuing operations
$
306,292

 
$
3,418

 
$
53,731

 
$
363,441

Net cash used by operating activities of discontinued operations

 
(102
)
 

 
(102
)
Net cash provided by operating activities
306,292

 
3,316

 
53,731

 
363,339

Investing Activities:
 
 
 
 
 
 

Acquisition of businesses, net of cash acquired

 

 
(44,426
)
 
(44,426
)
Property, plant and equipment acquired
(4,706
)
 
(23,130
)
 
(63,241
)
 
(91,077
)
Proceeds from sale of property, plant and equipment

 
6,512

 
3,451

 
9,963

Other investing activities, net
16

 
(1,052
)
 
1,089

 
53

Net cash used by investing activities
(4,690
)
 
(17,670
)
 
(103,127
)
 
(125,487
)
Financing Activities:
 
 
 
 
 
 


Common stock issued
13,346

 

 

 
13,346

Dividends paid
(74,945
)
 

 

 
(74,945
)
Repayments of Term Loan
(37,500
)
 

 

 
(37,500
)
Financing fees
(2,826
)
 

 

 
(2,826
)
Treasury stock purchased
(269,336
)
 

 

 
(269,336
)
Other financing activities, net
1,632

 
10,422

 
(8,090
)
 
3,964

Net cash used by financing activities
(369,629
)
 
10,422

 
(8,090
)
 
(367,297
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 
(6,073
)
 
(6,073
)
Decrease in cash, cash equivalents and restricted cash
(68,027
)
 
(3,932
)
 
(63,559
)
 
(135,518
)
Cash, cash equivalents and restricted cash at beginning of period
122,901

 
20,361

 
262,447

 
405,709

Cash, cash equivalents and restricted cash at end of period
$
54,874

 
$
16,429

 
$
198,888

 
$
270,191

Condensed Consolidating Statement of Cash Flows
Year Ended October 28, 2016
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 
 
Net cash provided (used) by operating activities
$
213,831

 
$
(17,962
)
 
$
57,772

 
$
253,641

Investing Activities:
 
 
 
 
 
 
 
Property, plant and equipment acquired
(618
)
 
(8,883
)
 
(33,189
)
 
(42,690
)
Proceeds from sale of business

 
28,250

 

 
28,250

Proceeds from sale of property, plant and equipment

 
18,063

 
6,775

 
24,838

Other investing activities, net
(744
)
 

 

 
(744
)
Net cash provided (used) by investing activities
(1,362
)
 
37,430

 
(26,414
)
 
9,654

Financing Activities:
 
 
 
 
 
 
 
Common stock issued
639

 

 

 
639

Dividends paid
(3,984
)
 

 

 
(3,984
)
Repayments of Term Loan
(18,750
)
 

 

 
(18,750
)
Payments on Credit Agreement
(58,600
)
 

 

 
(58,600
)
Financing fees
(1,011
)
 

 

 
(1,011
)
Other financing activities, net

 

 
(2,984
)
 
(2,984
)
Net cash used by financing activities
(81,706
)



(2,984
)

(84,690
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 
(3,271
)
 
(3,271
)
Increase in cash, cash equivalents and restricted cash
130,763

 
19,468

 
25,103

 
175,334

Cash, cash equivalents and restricted cash at beginning of period
581

 
2,008

 
100,296

 
102,885

Cash, cash equivalents and restricted cash at end of period
$
131,344

 
$
21,476

 
$
125,399

 
$
278,219


Condensed Consolidating Statement of Cash Flows
Year Ended October 30, 2015
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 
 
Net cash provided by operating activities
261,293

 
16,105

 
77,935

 
355,333

Investing Activities:
 
 
 
 
 
 
 
Acquisition of businesses, net of cash acquired

 

 
(114,353
)
 
(114,353
)
Property, plant and equipment acquired
(945
)
 
(19,108
)
 
(51,283
)
 
(71,336
)
Proceeds from sale of property, plant and equipment
942

 
216

 
3,142

 
4,300

Other investing activities, net
(1,148
)
 

 
1,065

 
(83
)
Net cash used by investing activities
(1,151
)
 
(18,892
)
 
(161,429
)
 
(181,472
)
Financing Activities:
 
 
 
 
 
 
 
Common stock issued
4,654

 

 

 
4,654

Dividends paid
(77,950
)
 

 

 
(77,950
)
Redemption of 6% note due 2016
(250,000
)
 

 

 
(250,000
)
Borrowings on Credit Agreement
58,600

 

 

 
58,600

Treasury stock purchased
(50,000
)
 

 

 
(50,000
)
Other financing activities, net
261

 
(11,634
)
 
1,113

 
(10,260
)
Net cash (used) provided by financing activities
(314,435
)

(11,634
)

1,113


(324,956
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 
(16,211
)
 
(16,211
)
Decrease in cash, cash equivalents and restricted cash
(54,293
)
 
(14,421
)
 
(98,592
)
 
(167,306
)
Cash, cash equivalents and restricted cash at beginning of period
54,874

 
16,429

 
198,888

 
270,191

Cash, cash equivalents and restricted cash at end of period
$
581

 
$
2,008

 
$
100,296

 
$
102,885


Condensed Consolidating Statement of Cash Flows
Year Ended October 31, 2014
In thousands
Parent
Company
 
Supplemental
Subsidiary
Guarantors
 
Supplemental
Non-Guarantor
Subsidiaries
 
Consolidated
Operating Activities:
 
 
 
 
 
 
 
Net cash provided by operating activities of continuing operations
$
306,292

 
$
3,418

 
$
53,731

 
$
363,441

Net cash used by operating activities of discontinued operations

 
(102
)
 

 
(102
)
Net cash provided by operating activities
306,292

 
3,316

 
53,731

 
363,339

Investing Activities:
 
 
 
 
 
 

Acquisition of businesses, net of cash acquired

 

 
(44,426
)
 
(44,426
)
Property, plant and equipment acquired
(4,706
)
 
(23,130
)
 
(63,241
)
 
(91,077
)
Proceeds from sale of property, plant and equipment

 
6,512

 
3,451

 
9,963

Other investing activities, net
16

 
(1,052
)
 
1,089

 
53

Net cash used by investing activities
(4,690
)
 
(17,670
)
 
(103,127
)
 
(125,487
)
Financing Activities:
 
 
 
 
 
 


Common stock issued
13,346

 

 

 
13,346

Dividends paid
(74,945
)
 

 

 
(74,945
)
Repayments of Term Loan
(37,500
)
 

 

 
(37,500
)
Financing fees
(2,826
)
 

 

 
(2,826
)
Treasury stock purchased
(269,336
)
 

 

 
(269,336
)
Other financing activities, net
1,632

 
10,422

 
(8,090
)
 
3,964

Net cash used by financing activities
(369,629
)
 
10,422

 
(8,090
)
 
(367,297
)
Effect of exchange rate changes on cash, cash equivalents and restricted cash

 

 
(6,073
)
 
(6,073
)
Decrease in cash, cash equivalents and restricted cash
(68,027
)
 
(3,932
)
 
(63,559
)
 
(135,518
)
Cash, cash equivalents and restricted cash at beginning of period
122,901

 
20,361

 
262,447

 
405,709

Cash, cash equivalents and restricted cash at end of period
$
54,874

 
$
16,429

 
$
198,888

 
$
270,191